青松股份(300132.SZ)取得兩項實用新型專利
格隆匯5月15日丨青松股份(300132.SZ)公佈,公司全資子公司諾斯貝爾化粧品股份有限公司近日收到了國家知識產權局頒發的《實用新型專利證書》,實用新型名稱:一種多功效型幹巾及所用的無紡布基布,本實用新型涉及一種多功效型幹巾,既可以用作多功效作用的精華液幹巾,也可以用作同時需要功效作用和擦濕作用的幹巾,還可以用作功效型幹巾鞋墊、功效型幹巾貼等;實用新型名稱:一種濕巾布摺疊器,本實用新型涉及一種濕巾布摺疊器,實現了摺疊質量一致,而且還可以根據消費者的需求,調節摺疊的寬度,提高了工效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.